84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]孫武,朱立國,高景華,等.手法松解聯(lián)合鹽酸乙哌立松片口服治療腰背肌筋膜炎的臨床研究[J].中醫(yī)正骨,2016,28(09):23-26.
　SUN Wu,ZHU Liguo,GAO Jinghua,et al.Clinical study on myofascial manipulative release combined with oral application of eperisone hydrochloride tablets for treatment of lumbodorsal myofascitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):23-26.
點擊復制

手法松解聯(lián)合鹽酸乙哌立松片口服治療腰背肌筋膜炎的臨床研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年09期
頁碼:
23-26
欄目:
臨床研究
出版日期:
2016-09-20

文章信息/Info

Title:
Clinical study on myofascial manipulative release combined with oral application of eperisone hydrochloride tablets for treatment of lumbodorsal myofascitis
作者:
孫武; 朱立國; 高景華; 張威; 高春雨; 銀河
中國中醫(yī)科學院望京醫(yī)院,北京 100102
Author(s):
SUN Wu; ZHU Liguo; GAO Jinghua; ZHANG Wei; GAO Chunyu; YIN He
Wangjing Hospital of China Academy Of Chinese Medical Sciences,Beijing 100102,China
關鍵詞:
筋膜炎;  腰背肌;  推拿; 脊柱;  神經(jīng)肌肉非去極藥;  布洛芬;  復發(fā)
Keywords:
fasciitis;  lumbodorsal muscles;  manipulation; spinal;  neuromuscular nondepolarizing agents;  ibuprofen;  recurrence
摘要:
目的:探討手法松解聯(lián)合鹽酸乙哌立松片口服治療腰背肌筋膜炎的臨床療效。方法:將60例腰背肌筋膜炎患者隨機分為觀察組和對照組,每組30例。觀察組采用手法松解聯(lián)合鹽酸乙哌立松片口服治療,對照組采用芬必得布洛芬緩釋膠囊加鹽酸乙哌立松片口服治療。治療前后分別采用視覺模擬評分量表(visual analogue scale,VAS)和Oswestry功能障礙指數(shù)(Oswestry disability index,ODI)對患者腰背部疼痛和腰椎功能進行評估。治療結束后即根據(jù)ODI改善率評價療效,并隨訪觀察2組患者臨床復發(fā)情況,記錄復發(fā)時間。結果:治療前2組患者VAS評分和ODI評分組間比較,差異均無統(tǒng)計學意義[(7.3±0.9)分,(7.2±1.1)分; t=0.381,P=0.352;(40.4±4.7)分,(39.9±3.5)分; t=0.499,P=0.309]。治療結束后2組患者VAS評分和ODI評分均較治療前降低[(7.3±0.9)分,(1.5±0.6)分; t=28.987,P=0.000;(7.2±1.1)分,(1.9±0.8)分; t=21.399,P=0.000;(40.4±4.7)分,(11.6±2.9)分; t=28.665,P=0.000;(39.9±3.5)分,(13.9±2.9)分; t=31.456,P=0.000]; 且觀察組VAS評分和ODI評分均低于對照組[(1.5±0.6)分,(1.9±0.8)分; t=2.633,P=0.005;(11.6±2.9)分,(13.9±2.9)分; t=-3.107,P=0.001]。根據(jù)ODI改善率評價療效,觀察組優(yōu)8例、良22例; 對照組優(yōu)1例、良27例、可2例; 觀察組療效優(yōu)于對照組(Z=-2.793,P=0.005)。60例患者均獲隨訪,隨訪時間12～36個月,中位數(shù)22個月。60例患者均出現(xiàn)復發(fā); 治療結束至癥狀復發(fā)的時間觀察組(17.1±7.5)個月,對照組(12.2±6.5)個月; 觀察組復發(fā)較對照組晚(t=2.764,P=0.004)。結論:手法松解聯(lián)合鹽酸乙哌立松片口服治療腰背肌筋膜炎,可有效緩解疼痛、改善腰椎功能,療效優(yōu)于芬必得布洛芬緩釋膠囊加鹽酸乙哌立松片口服,且更有利于延緩復發(fā)。
Abstract:
Objective:To explore the clinical curative effects of myofascial manipulative release combined with oral application of eperisone hydrochloride tablets for treatment of lumbodorsal myofascitis.Methods:Sixty patients with lumbodorsal myofascitis were randomly divided into observation group and control group,30 cases in each group.The patients in observation group were treated with myofascial manipulative release combined with oral application of eperisone hydrochloride tablets,while the patients in control group were treated with oral application of ibuprofen sustained-release capsules and eperisone hydrochloride tablets.The lumbodorsal pain and lumbar function were evaluated by using visual analogue scale(VAS)and Oswestry disability index(ODI)respectively before and after the treatment.The curative effect was evaluated according to the ODI improvement rate after the end of the treatment and the patients were followed up.The clinical recurrences were observed and the recurrence time was recorded.Results:There was no statistical difference in VAS scores and ODI scores between the 2 groups before treatment(7.3+/-0.9 vs 7.2+/-1.1 points,t=0.381,P=0.352; 40.4+/-4.7 vs 39.9+/-3.5 points,t=0.499,P=0.309).The VAS scores and ODI scores decreased in both of the 2 groups after the end of the treatment compared to pre-treatment(7.3+/-0.9 vs 1.5+/-0.6 points,t=28.987,P=0.000; 7.2+/-1.1 vs 1.9+/-0.8 points,t=21.399,P=0.000; 40.4+/-4.7 vs 11.6+/-2.9 points,t=28.665,P=0.000; 39.9+/-3.5 vs 13.9+/-2.9 points,t=31.456,P=0.000).The VAS scores and ODI scores were lower in observation group compared to control group(1.5+/-0.6 vs 1.9+/-0.8 points,t=2.633,P=0.005; 11.6+/-2.9 vs 13.9+/-2.9 points,t=-3.107,P=0.001).According to the ODI improvement rate,8 patients obtained an excellent result and 22 good in observation group; while 1 patient obtained an excellent result,27 good and 2 fair in control group.Theobservation group surpassed the control group in the total curative effects(Z=-2.793,P=0.005).Sixty patients in the 2 groups were followed up for 12-36 months with a median of 22 months.The recurrence was found in all of the patients.The time from end-of-treatment to symptom recurrence was longer in observation group(17.1+/-7.5 months)compared to control group(12.2+/-6.5 months)and there was statistical difference between the 2 groups(t=2.764,P=0.004).Conclusion:The combination therapy of myofascial manipulative release and oral application of eperisone hydrochloride tablets can effectively relieve lumbodorsal pain and improve lumbar function in the treatment of lumbodorsal myofascitis,moreover,its curative effect is better than that of oral application of ibuprofen sustained-release capsules and eperisone hydrochloride tablets,and it is more conducive to delaying the recurrence.

參考文獻/References:

[1] 彭亦良,張彥,李永鋒,等.電針、推拿及中頻理療治療腰背肌筋膜炎的前瞻、隨機、對照性研究[J].現(xiàn)代中西醫(yī)結合雜志,2013,22(1):13-15. [2] 孫樹椿,孫之鎬.臨床骨科學[M].北京:人民衛(wèi)生出版社,2006:861-864. [3] Carlsson AM.Assessment of chronic pain.Aspects of the reliability and validity of the visual analogue scale[J].Pain,1983,16(1):87-101. [4] Roland M,Fairbank J.The Roland-Morris disability questionnaire and the oswestry disability questionnaire[J].Spine(Phila Pa 1976),2000,25(24):3115-3124. [5] Fairbank JC.Oswestry disability index[J].J Neurosurg Spine,2014,20(2):239-241. [6] Stanton TR,Latimer J,Maher CG,et al.A modified Delphi approach to standardize low back pain recurrence terminology[J].Eur Spine J,2011,20(5):744-752. [7] Young AE,Wasiak R,Gross DP.Recurrence of work-related low back pain and disability:association between self-report and workers'compensation data[J].Spine(Phila Pa 1976),2013,38(26):2279-2286. [8] Chandanwale AS,Chopra A,Goregaonkar A,et al.Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain:A randomized,double-blind,placebo-controlledtrial[J].J Postgrad Med,2011,57(4):278-285. [9] Bhattarai S,Chhetri HP,Alam K,et al.A study on factors affecting low back pain and safety and efficacy of NSAIDs in acute low back pain in a tertiary care hospital of Western Nepal[J].J Clin Diagn Res,2013,7(12):2752-2758. [10] 林樺楠,陳海鵬,丘宏龍,等.針灸聯(lián)合正清風痛寧離子導入治療慢性腰背肌筋膜炎36例[J].中國中醫(yī)骨傷科雜志,2015,23(1):41-43. [11] 許毅強.平刺針刀治療背肌筋膜炎32例[J].中國針灸,2012,32(12):1127-1128. [12] Rossi M,Ianigro G,Liberatoscioli G,et al.Eperisone versus tizanidine for treatment of chronic low back pain[J].Minerva Med,2012,103(3):143-149. [13] 牛寧奎,馬文鑫,王自立,等.雙氯芬酸、乙哌立松及甲鈷胺聯(lián)合治療下腰痛的臨床療效分析[J].中國中醫(yī)骨傷科雜志,2011,19(9):34-35. [14] 劉榮新,崔蓮玉,于蘭先.閉式松解治療大面積腰背肌筋膜炎[J].中醫(yī)正骨,2012,24(2):60. [15] 宋豐軍,胡建鋒,張紅,等.推拿治療慢性腰肌勞損的臨床研究進展[J].中醫(yī)正骨,2014,26(12):59-63.

相似文獻/References:

[1]龐青民,趙欲曉.筋針療法治療腰背肌筋膜炎[J].中醫(yī)正骨,2017,29(03):36.
[2]葉永亮,霍力為,羅曼,等.跟痛癥相關的解剖學研究[J].中醫(yī)正骨,2019,31(02):1.
　YE Yongliang,HUO Liwei,LUO Man,et al.An anatomical study associated with calcaneodynia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(09):1.
[3]吳海洋,吳軍豪,聞國偉,等.黑虎丹在骨傷科疾病治療中的應用[J].中醫(yī)正骨,2020,32(05):49.
[4]劉文東,李國梁,邢寶瑞,等.嗜水氣單胞菌致膿毒性休克2例[J].中醫(yī)正骨,2023,35(05):75.

備注/Memo

備注/Memo:
2016-02-29收稿 2016-08-02修回
朱立國 E-mail:[email protected]

更新日期/Last Update: 1900-01-01